Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases.

MLA

Sgarabotto, Dino, et al. “Synercid plus Vancomycin for the Treatment of Severe Methicillin-Resistant Staphylococcus Aureus and Coagulase-Negative Staphylococci Infections: Evaluation of 5 Cases.” Scandinavian Journal of Infectious Diseases, vol. 34, no. 2, 2002, pp. 122–26. EBSCOhost, https://doi.org/10.1080/00365540110077245.

APA

Sgarabotto, D., Cusinato, R., Narne, E., Scano, F., Zignol, M., Gambino, A., Cattelan, A., Meneghetti, F., & Cadrobbi, P. (2002). Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases. Scandinavian Journal of Infectious Diseases, 34(2), 122–126. https://doi.org/10.1080/00365540110077245

Chicago

Sgarabotto, Dino, Riccardo Cusinato, Elena Narne, Fabio Scano, Matteo Zignol, Antonio Gambino, Annamaria Cattelan, Francesco Meneghetti, and Paolo Cadrobbi. 2002. “Synercid plus Vancomycin for the Treatment of Severe Methicillin-Resistant Staphylococcus Aureus and Coagulase-Negative Staphylococci Infections: Evaluation of 5 Cases.” Scandinavian Journal of Infectious Diseases 34 (2): 122–26. doi:10.1080/00365540110077245.